Table 1 Clinico-demographic of the studied children with T1DM on insulin pump during COVID-19 pandemic
Children with T1DM on insulin pump during COVID-19 No. = 42 | |
|---|---|
Age (Year) | |
Mean ± SD | 12.31 ± 3.28 |
Range | 7–18 |
Gender | |
Female | 27 (64.3%) |
Male | 15 (35.7%) |
Duration of diabetes (Years) | |
Mean ± SD | 5.40 ± 2.93 |
Range | 2–13 |
Weight z-score | |
Median (IQR) | -0.31 (-0.79–0.61) |
Range | -1.5–2.28 |
Height z-score | |
Median (IQR) | 0.04 (-0.82–0.52) |
Range | -2.3–2.31 |
BMI z-score | |
Median (IQR) | -0.19 (-0.62–0.64) |
Range | -2.49–2.89 |
Insulin dose (unit/Kg/day) | |
Mean ± SD | 0.88 ± 0.30 |
Range | 0.5–1.8 |
Basal percentage (%) | |
Mean ± SD | 52.74 ± 4.31 |
Range | 50–60 |
ICR | |
Median (IQR) | 15 (10–20) |
Range | 8–50 |
ISF | |
Median (IQR) | 52.5 (40–80) |
Range | 20–150 |
Insulin pump problems | |
Positive | 29 (69.0%) |
Skin irritation | 13 (31.0%) |
Skin infection | 3 (7.1%) |
Pump obstruction | 13 (31.0%) |
Availability of insulin pump supplies | |
Positive | 42 (100.0%) |
DKA / year | |
Positive | 6 (14.3%) |
Frequency of hypoglycemia /week | |
Median (IQR) | 3 (2–3) |
Range | 0–7 |
Frequency of nocturnal hypoglycemia /week | |
Median (IQR) | 2 (1–3) |
Range | 1–4 |